118 related articles for article (PubMed ID: 3332748)
41. Benign non-X histiocytosis: a unique case bridging several of the non-X histiocytic syndromes.
Coldiron BM; Cruz PD; Freeman RG; Sontheimer RD
J Am Acad Dermatol; 1988 Jun; 18(6):1282-9. PubMed ID: 3385043
[TBL] [Abstract][Full Text] [Related]
42. Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature.
Shan SJ; Meng LH; Lu R; Guo Y
Am J Dermatopathol; 2015 Aug; 37(8):639-42. PubMed ID: 25321088
[TBL] [Abstract][Full Text] [Related]
43. Phenotype, ultrastructure, and function of CD1+DR+ epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma.
Lisby S; Baadsgaard O; Cooper KD; Hansen ER; Mehregan D; Thomsen K; Allen E; Lange Vejlsgaard G
Scand J Immunol; 1990 Aug; 32(2):111-9. PubMed ID: 1697095
[TBL] [Abstract][Full Text] [Related]
44. A distinctive cutaneous malignant neoplasm expressing the Langerhans cell phenotype. Synchronous occurrence with B-chronic lymphocytic leukemia.
Bonetti F; Knowles DM; Chilosi M; Pisa R; Fiaccavento S; Rizzuto N; Zamboni G; Menestrina F; Fiore-Donati L
Cancer; 1985 May; 55(10):2417-25. PubMed ID: 3886125
[TBL] [Abstract][Full Text] [Related]
45. Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies.
Ralfkiaer E; Lange Wantzin G; Mason DY; Stein H; Thomsen K
Br J Dermatol; 1984 Dec; 111(6):635-45. PubMed ID: 6391533
[TBL] [Abstract][Full Text] [Related]
46. [Regressive atypical histiocytosis (or Ki-1 lymphoma of the skin). Presentation of a case with an immunohistochemical study].
Muretto P; Mancini G; Carbone F
G Ital Dermatol Venereol; 1989 Apr; 124(4):151-7. PubMed ID: 2807393
[TBL] [Abstract][Full Text] [Related]
47. Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy.
Kyogoku C; Seki M; Ogawa S; Miyamoto K; Ito Y; Kurita N; Yokoyama Y; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Fujishima F; Ichinohasama R; Nakamura S; Chiba S
J Clin Exp Hematop; 2015; 55(1):33-7. PubMed ID: 26106005
[TBL] [Abstract][Full Text] [Related]
48. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
49. Specific cutaneous lesions in a CD8+ peripheral T-cell lymphoma.
Marti RM; Estrach T; Palou J; Urbano-Ispizua A; Gratacos J; Cervera R; Feliu E; Grau JM; Mascaro JM
Int J Dermatol; 1992 Sep; 31(9):624-8. PubMed ID: 1459758
[TBL] [Abstract][Full Text] [Related]
50. Sinus histiocytosis with massive lymphadenopathy. A nodal and extranodal proliferation of S-100 protein positive histiocytes?
Miettinen M; Paljakka P; Haveri P; Saxén E
Am J Clin Pathol; 1987 Sep; 88(3):270-7. PubMed ID: 3630972
[TBL] [Abstract][Full Text] [Related]
51. Solitary Langerhans cell histiocytoma.
Taïeb A; de Mascarel A; Surlève-Bazeille JE; Gauthier Y; Legrain V; Maleville J
Arch Dermatol; 1986 Sep; 122(9):1033-7. PubMed ID: 3017234
[TBL] [Abstract][Full Text] [Related]
52. Fatal systemic cytophagic histiocytic panniculitis: a histopathologic and immunohistochemical study of multiple organ sites.
Perniciaro C; Winkelmann RK; Ehrhardt DR
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 2):901-5. PubMed ID: 7962745
[TBL] [Abstract][Full Text] [Related]
53. Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes.
Eckert F; Schmid U; Kaudewitz P; Burg G; Braun-Falco O
Am J Dermatopathol; 1989 Aug; 11(4):345-52. PubMed ID: 2549799
[TBL] [Abstract][Full Text] [Related]
54. Langerhans cell sarcoma: a case report.
Valentín-Nogueras SM; Seijo-Montes R; Montalván-Miró E; Sánchez JL
J Cutan Pathol; 2013 Jul; 40(7):670-5. PubMed ID: 23590692
[TBL] [Abstract][Full Text] [Related]
55. A case of multifocal proliferations of histiocytic cells containing Langerhans' cell granules.
Kato T; Matsuda M; Ando H; Sasaki H
Am J Clin Pathol; 1981 Oct; 76(4):480-5. PubMed ID: 6975032
[TBL] [Abstract][Full Text] [Related]
56. Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics.
Wood GS; Turner RR; Shiurba RA; Eng L; Warnke RA
Am J Pathol; 1985 Apr; 119(1):73-82. PubMed ID: 3985124
[TBL] [Abstract][Full Text] [Related]
57. A case of indeterminate dendritic cell tumor presenting with leonine facies.
Oh CW; Ivan D; Curry JL; Ellis R; Gerber H; Duvic M; Torres-Cabala C
J Cutan Pathol; 2016 Feb; 43(2):158-63. PubMed ID: 26272726
[TBL] [Abstract][Full Text] [Related]
58. Langerhans cell histiocytosis localized to the eyelid.
Chikama T; Yoshino H; Nishida T; Nagasawa T; Takahashi M; Iwata T
Arch Ophthalmol; 1998 Oct; 116(10):1375-7. PubMed ID: 9790643
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].
Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Maeshiro H; Shigematsu H; Matsumi N; Matsumoto K; Furuta T; Nishimoto A
No To Shinkei; 1989 Dec; 41(12):1195-201. PubMed ID: 2697376
[TBL] [Abstract][Full Text] [Related]
60. [Tumors of dendritic and other accessory cells of lymph nodes].
Tzankov A; Dirnhofer S
Pathologe; 2015 Sep; 36(5):467-76. PubMed ID: 26305140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
